Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shi
    Wei Shi
    • Feb 2010
    • 236

    #1

    <30% of reads mapped

    I tried using bowtie (0.12.2) to mapping Illumina GAII reads to human genome. However, the percentage of reads which were mapped (reads with at least one reported alignment) is less than 30%. The length of these reads is 100bp.

    I also have the GAII read data which included 50bp reads (same sample). More than 80% of reads can be mapped using bowtie.

    I used the default parameters to run bowtie. Should I adjust the parameter for aligning 100 bp or bowtie is not suitable for mapping reads longer than 50 bp?

    I notice that in Table 3 of the bowtie paper the percentage of mapped reads for 76 bp reads is 44.5% (31.7% if using option -v 2), which is much lower than the percentages for 50bp reads and 36 bp reads in the same table.


    Thanks,
    Wei
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    bowtie has options (--trim5 & --trim3) for removing N bases from the 5' or 3' end of read -- have you tried this to truncate your reads down to 50nt & see if you get much mapping.

    You might also take 10-20 reads or so with high quality scores & BLASTN them (easy to do at NCBI) against all known sequences -- this would check for a sample swap (to another species).

    Comment

    • dcfargo
      Member
      • Aug 2008
      • 22

      #3
      I'd drop the -v go with -n (perhaps make -l a little longer than default) and 'titrate' the -e value using a subset of the sequences.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Working...